CeaVac trial reaches accrual goal; phase II trial will be expanded to phase III Dec. 23, 1999 No Comments
StressGen's new treatment for cervical dysplasia successfully completes phase I study Dec. 14, 1999 No Comments
Cell Genesys receives payment from Japan Tobacco for cancer vaccine milestone Dec. 14, 1999 No Comments
KRN-7000-stimulated human cells effective in vitro against melanoma cell lines Dec. 13, 1999 No Comments
LifeTime receives FDA clearance to begin phase I/II trials of anticancer drug Dec. 10, 1999 No Comments